Together we will beat cancer

Donate

ASCO 2019 news: targeted treatment takeover, drugging the ‘undruggable’, obesity and blood tests

The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.

Read More

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

Read More

ASCO 2018 news: ‘blood tests’, breast cancer chemo, kinder treatments and immunotherapy

The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment.

Read More

6 tips to spot cancer ‘fake news’

How can you tell if there’s more to the latest cancer news than meets the eye? Here are a few tips to help you judge a story for yourself.

Read More

News digest – Testosterone, artificial intelligence, genetic tests, the HPV vaccine and… a cuppa?

Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.

Read More

NCRI 2017: How knowing tumours inside and out is boosting progress

In our round-up of this year’s NCRI conference we reveal exciting new research that’s helping scientists get to know cancer better.

Read More

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Read More

News digest – Improving prostate cancer survival, a life-extending app, yoga and… a tribute to Professor Patrick Johnston.

Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.

Read More

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

Read More

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

Read More